Zheng Hua-Chuan, Tsuneyama Koichi, Takahashi Hiroyuki, Miwa Shigeharu, Sugiyama Toshiro, Popivanova Boryana Konstantinova, Fujii Chifumi, Nomoto Kazuhiro, Mukaida Naofumi, Takano Yasuo
Department of Diagnostic Pathology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
J Cancer Res Clin Oncol. 2008 Apr;134(4):481-8. doi: 10.1007/s00432-007-0310-1. Epub 2007 Sep 18.
Pim-3, a member of the proto-oncogene Pim family with serine/threonine kinase activity was aberrantly expressed in cancerous lesions of endoderm-derived organs such as liver, pancreas, and colon. The aim of this study was to clarify the role of Pim-3 expression in the tumorigenesis and the development of gastric carcinomas.
Pim-3 expression was immunohistochemically examined on the tissue microarrays containing primary (n = 285) and metastastic (n = 37) sites of gastric carcinomas, in comparison with adenoma (n = 48) and non-cancerous mucosa (n = 84). It was also compared with the clinicopathological parameters of gastric carcinomas.
Pim-3 expression was enhanced in adenoma (64.6%) and metastasis sites of gastric carcinoma (73.0%), to a lesser degree in primary sites of gastric carcinoma (39.3%) when compared to non-cancerous mucosa (13.1%, p < 0.0001). Pim-3 expression levels were higher in intestinal-type than diffuse-type gastric carcinoma (p = 0.018). Pim-3 expression was closely correlated with sex (p = 0.047), lymphatic (p = 0.019) and venous invasion (p = 0.014). Pim-3 expression was correlated significantly with vascular endothelial growth factor (VEGF, p = 0.009) and extracellular matrix metalloproteinase inducer (EMMPRIN, p = 0.032), both of which are presumed to be involved in neovascularization, a crucial step for metastasis. On the contrary, phosphatase and tensin homology deleted from human chromosome 10 (Pten) negative gastric carcinomas exhibited higher Pim-3 expression than Pten positive ones (p = 0.042). There was no relationship between Pim-3 expression and MVD in gastric carcinomas (p = 0.715). Furthermore, patients with Pim-3 positive gastric cancer, showed a lower cumulative survival rate than those with Pim-3 negative gastric cancer (p = 0.014) and Pim-3 positive was also identified as an independent prognostic factor for gastric carcinoma patients (p = 0.006).
Aberrant Pim-3 expression was involved in gastric adenoma-adenocarcinoma sequence and subsequent invasion and metastasis process in gastric cancer. Moreover, Pim-3 may be employed to predict the prognosis of gastric cancer patients. Distinct Pim-3 expression underlies the molecular mechanisms for the differentiation of intestinal-type and diffuse-type carcinomas.
Pim-3是原癌基因Pim家族成员,具有丝氨酸/苏氨酸激酶活性,在内胚层来源器官如肝脏、胰腺和结肠的癌性病变中异常表达。本研究旨在阐明Pim-3表达在胃癌发生发展中的作用。
采用免疫组织化学方法检测包含胃癌原发灶(n = 285)和转移灶(n = 37)的组织芯片中Pim-3的表达,并与腺瘤(n = 48)和非癌黏膜(n = 84)进行比较。同时将其与胃癌的临床病理参数进行比较。
与非癌黏膜(13.1%,p < 0.0001)相比,腺瘤(64.6%)和胃癌转移灶(73.0%)中Pim-3表达增强,胃癌原发灶中Pim-3表达增强程度较低(39.3%)。肠型胃癌中Pim-3表达水平高于弥漫型胃癌(p = 0.018)。Pim-3表达与性别(p = 0.047)、淋巴管浸润(p = 0.019)和静脉浸润(p = 0.014)密切相关。Pim-3表达与血管内皮生长因子(VEGF,p = 0.009)和细胞外基质金属蛋白酶诱导剂(EMMPRIN,p = 0.032)显著相关,这两者均被认为参与了转移的关键步骤——新生血管形成。相反,10号染色体缺失的磷酸酶和张力蛋白同源物(Pten)阴性的胃癌中Pim-3表达高于Pten阳性的胃癌(p = 0.042)。胃癌中Pim-3表达与微血管密度(MVD)无关(p = 0.715)。此外,Pim-3阳性胃癌患者的累积生存率低于Pim-3阴性胃癌患者(p = 0.014),且Pim-3阳性被确定为胃癌患者的独立预后因素(p = 0.006)。
Pim-3异常表达参与了胃腺瘤-腺癌序列以及随后胃癌的侵袭和转移过程。此外,Pim-3可用于预测胃癌患者的预后。不同的Pim-3表达是肠型和弥漫型癌分化的分子机制基础。